Evidence map›Paper›PMID 35093235›Full record

ArticleCell reports2022

Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.

Jie Zhou, Thomas P Peacock, Jonathan C Brown, Daniel H Goldhill, Ahmed M E Elrefaey, Rebekah Penrice-Randal, Vanessa M Cowton, Giuditta De Lorenzo, Wilhelm Furnon, William T Harvey and 19 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 6 institutions in 3 countries.

Jie ZhouDepartment of Infectious Disease, Imperial College London, London, UK.
Thomas P PeacockDepartment of Infectious Disease, Imperial College London, London, UK.
Jonathan C BrownDepartment of Infectious Disease, Imperial College London, London, UK.
Daniel H GoldhillDepartment of Infectious Disease, Imperial College London, London, UK.
Ahmed M E ElrefaeyThe Pirbright Institute, Woking, Surrey, UK.
Rebekah Penrice-RandalInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK.
Vanessa M CowtonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Giuditta De LorenzoMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Wilhelm FurnonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
William T HarveyMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Ruthiran KugathasanDepartment of Infectious Disease, Imperial College London, London, UK.
Rebecca FriseDepartment of Infectious Disease, Imperial College London, London, UK.
Laury BaillonDepartment of Infectious Disease, Imperial College London, London, UK.
Ria LassaunièreVirus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Nazia ThakurThe Pirbright Institute, Woking, Surrey, UK; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Giulia GalloThe Pirbright Institute, Woking, Surrey, UK.
Hannah GoldswainInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK.
I'ah Donovan-BanfieldInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK.
Xiaofeng DongInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK.
Nadine P RandleInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK.
Fiachra SweeneyDepartment of Infectious Disease, Imperial College London, London, UK.
Martha C GlynnDepartment of Infectious Disease, Imperial College London, London, UK.
Jessica L QuantrillDepartment of Infectious Disease, Imperial College London, London, UK.
Paul F McKayDepartment of Infectious Disease, Imperial College London, London, UK.
Arvind H PatelMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Julian A HiscoxInstitute of Infection, Veterinary and Ecology Sciences, University of Liverpool, Liverpool, UK; Infectious Diseases Horizontal Technology Centre (ID HTC), A(∗)STAR, Singapore, Singapore.
Dalan BaileyThe Pirbright Institute, Woking, Surrey, UK.
Wendy S BarclayDepartment of Infectious Disease, Imperial College London, London, UK. Electronic address: w.barclay@imperial.ac.uk.
Imperial College London · GBMRC University of Glasgow Centre for Virus Research · GBUniversity of Liverpool · GBThe Pirbright Institute · GBAgency for Science, Technology and Research · SGStatens Serum Institut · DK

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Biotechnology and Biological Sciences Research Council BBS/E/I/COV07001Medical Research Council MC_PC_19026Medical Research Council MC_UU_12014/10Medical Research Council MC_UU_12014/2Medical Research Council MR/W005611/1Wellcome Trust
6 · The paper itself

Abstract

SARS-CoV-2 has a broad mammalian species tropism infecting humans, cats, dogs, and farmed mink. Since the start of the 2019 pandemic, several reverse zoonotic outbreaks of SARS-CoV-2 have occurred in mink, one of which reinfected humans and caused a cluster of infections in Denmark. Here we investigate the molecular basis of mink and ferret adaptation and demonstrate the spike mutations Y453F, F486L, and N501T all specifically adapt SARS-CoV-2 to use mustelid ACE2. Furthermore, we risk assess these mutations and conclude mink-adapted viruses are unlikely to pose an increased threat to humans, as Y453F attenuates the virus replication in human cells and all three mink adaptations have minimal antigenic impact. Finally, we show that certain SARS-CoV-2 variants emerging from circulation in humans may naturally have a greater propensity to infect mustelid hosts and therefore these species should continue to be surveyed for reverse zoonotic infections.

Indexed as

Adaptation, BiologicalAnimalsCOVID-19FerretsGenetic FitnessHumansMinkMutationPandemicsRespiratory SystemSARS-CoV-2Spike Glycoprotein, CoronavirusViral ZoonosesSpike Glycoprotein, CoronavirusACE2antigenicitycoronavirusCOVID-19ferretminkpandemicSARS-CoV-2zoonosis

Identifiers

PMID35093235
PMCPMC8768428
OpenAlexW4206586685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.